Literature DB >> 23731324

The first simultaneous kidney-adrenal gland-pancreas transplantation: outcome at 1 year.

J Vouillarmet1, F Buron, C Houzard, M C Carlier, C Chauvet, M Brunet, C Thivolet, E Morelon, L Badet.   

Abstract

Adrenal insufficiency is a rare but life-threatening disease. Replacement therapy sometimes fails to prevent an acute adrenal crisis and most often does not lead to restoration of well-being. We report here the 1-year outcome of the first simultaneous kidney-adrenal gland-pancreas transplantation in a 33-year-old patient with type 1 diabetes and concomitant autoimmune adrenal insufficiency. En bloc left adrenal gland and kidney grafts were anastomosed on the left iliac vessels in normal vascular conditions and the pancreas graft was anastomosed on the right iliac vessels. The immunosuppressive regimen was not modified by the addition of the adrenal gland. We observed no additional morbidity due to the adrenal gland transplantation, as there were no surgical complications. One-year kidney and pancreas graft functions were satisfactory (estimated glomerular filtration rate: 55 mL/min/1.73 m(2) and HbA1c: 4.8%). The adrenal graft functioned well at 12 months with a normalization of cortisol and aldosterone baseline levels. Functional imaging at 3 months showed good uptake of [(123) I]-metaiodobenzylguanidine by the adrenal graft. Transplantation of the adrenal gland en bloc with the left kidney appears to be a good therapeutic option in patients with adrenal insufficiency awaiting kidney or kidney-pancreas transplantation. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2013        PMID: 23731324     DOI: 10.1111/ajt.12296

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  2 in total

1.  Glucocorticoid replacement therapies: past, present and future.

Authors:  Su-Yi Liew; Scott A Akker; Leonardo Guasti; James F H Pittaway
Journal:  Curr Opin Endocr Metab Res       Date:  2019-09-04

Review 2.  New directions for the treatment of adrenal insufficiency.

Authors:  Gerard Ruiz-Babot; Irene Hadjidemetriou; Peter James King; Leonardo Guasti
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-06       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.